NCT02892123 2024-11-27
Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers
Jazz Pharmaceuticals
Phase 1 Completed
Jazz Pharmaceuticals
Novartis
New Mexico Cancer Research Alliance
GlaxoSmithKline
University of New Mexico
Hellenic Oncology Research Group
National Institutes of Health Clinical Center (CC)